Working Party Chairs and Secretaries
Acute Leukemia
The ALWP dedicated its activities to organizing educational activities; designing and activation of prospective trials in the field of acute leukemias across member centers; generating high quality retrospective studies addressing different issues related to acute leukemia therapy; generating guidelines pertinent to management of acute leukemia.
Currently, the ALWP’s activities are organised and structured within 6 subcommittees (SC) focused on specific fields of interest: Autologous SCT SC, Immunotherapy SC, Alternative donors SC, RIC SC, Molecular markers SC and the Developing centres SC.
ChairpersonMohamad MohtyCHU Nantes
Haematology Dept
1 Place Ricordeau
44035 Nantes France
SecretarySebastien GiebelDepartment of BMT, Maria Sklodowska-Curie Memorial Cancer Centre & Oncology Institute
Wybrzeze Armii Krajowej 15
44-101 Gliwice
POLAND
Severe Aplastic Anaemia
The SAAWP reports on Aplastic Anaemia (AA) and other rare acquired and inherited bone marrow failure disorders.
The SAAWP provides essential data on outcomes after treatment from large numbers of patients that can only be obtained from large registries like the EBMT. It also provides important clinical information needed to help classify and characterise the disease and data on the natural history of the disease and late effects that occur after treatment.
The SAAWP holds the Aplastic Anaemia (AA) database that is the only “disease specific” database within the EBMT. Data are collected not only on patients receiving transplants but also other forms of therapy, including immunosuppressive therapy.
ChairpersonJudith MarshGKT School of Medicine
Dept. of Haematological Medicine
King`s Denmark Hill Campus
SE5 9RS London
UK
SecretaryCarlo Dufour, MD Chair, Haematology Unit
G. Gaslini Children's Hospital
Largo G. Gaslino 5
16147 Genova
ITALY
Autoimmune Diseases
The ADWP is dedicated to promote clinical activities, teaching and translational researches, mainly autologous /allogeneic HSCT together with of novel forms of cellular therapies and new immunosuppressive drugs in a specific challenge to induce tolerance and to better understand the possibility of resetting the immune response during treatment of severe autoimmune diseases.
The ADWP has a strategic role of interaction with other Autoimmune Diseases (AD) specialists and their respective scientific societies.
ChairpersonDominique Farge-BancelService de Médecine Interne
Hopital St Louis
1 avenue Claude Vellefaux
75 010 Paris
FRANCE
SecretaryJohn SnowdenNorth Trent BMT - Programme (Adults)
Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital (c/o Room H104)
Glossop Road
S10 2JF Sheffield
Chronic Malignancies
The CLWP promotes and conduct educational activities and clinical investigations on HSCT in chronic leukaemias, myelodysplastic/proliferative syndromes and plasma cell disorders as well as on the early complications that can be caused by HSCT in order to improve treatment strategies and quality of life for patients.
The CLWP consists of five subcommittees: chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), multiple myeloma (MM), myelodysplastic syndromes/myeloproliferative syndromes (MDS/MPD) and complications.
The CLWP works in cooperation with several Working Groups of the European LeukemiaNet, ERIC, Myeloma Network, national transplant groups, and with the IBMTR.
ChairpersonNicolaus KrögerUniversity Hospital Eppendorf
Bone Marrow Transplantation Centre
Martinistr. 52
20251 Hamburg
GERMANY
Tel: +49 40 79105 4850 / 4851 /5250
Fax: +49 40 74105 /3795
nkroeger@uke.uni-hamburg.de
SecretaryLaurent Garderet
Hôpital Saint Antoine,
Service d'hématologie
184, rue du Faubourg
Saint Antoine 75571
Paris Cedex 12
FRANCE
Tel: +33(0)1 49 28 26 21
Fax: +33(0)1 49 28 32 00
Immunobiology
The IWP strengthenes its key role in translating basic science into clinical applications by deepening understanding of the immunology of haematopoietic transplantation and integrating immune intervention to improve transplantation outcomes.
ChairpersonAndrea VelardiOspedale Santa Maria delle Misericordia - Sezione di Ematologia
Dipartimento di Medicina Clinica e Sperimentale,
Localitá Sant Andrea delle Fratte,
06122 Perugia
ITALY
Tel: +39 075 578 4124
Fax: +39 075 578 4170
velardi@unipg.it
Inborn Errors
The IEWP is dedicated to improving the outcome of transplantation for inborn errors of metabolism including severe congenital immunodeficiencies and metabolic diseases.
The IEWP aim to do this through the exchange of ideas and transplant data; international collaborative retrospective studies to look at the outcome of transplant for these conditions; the development of transplant guidelines and the education of transplant physicians worldwide; the development and use of a common registry to document and analyse results of treatment.
Click on the following links to read:
EBMT/ESID guidelines for Haematopoietic Stem Cell Transplantation for primary immunodeficiencies.
Osteopetrosis Consensus guidelines for diagnosis, therapy and follow-up.
ChairpersonBobby Gaspar Molecular Immunology Unit
UCL Institute of Child Health
30 Guilford Street
London WC1N 1EH
UNITED KINGDOM
Tel: +44 (0)207 905 2319/2289 (direct/secretary)
Fax: +44 (0)207 905 2810
h.gaspar@ucl.ac.uk
SecretaryFulvio Porta Onco-haematology and BMT Unit
Ospedale dei Bambini "Umberto I"
Brescia,
ITALY
ChairpersonSimone CesaroPaediatric Haematology Oncology
Policlinico G.B. Rossi
Piazzale L.A. Scuro, 10
37134 Verona
ITALY
SecretaryJan StyczynskiDepartment of Paediatric Haematology and Oncology, Laboratory of Clinical and Experimental Oncology
Medical University of Bydgoszcz
Poland
jstyczynski@cm.umk.pl
Transplant-related Complications and Quality of Life after SCT
The aim of the LEWP is to assess general health status, malignant and non-malignant late effects and quality of life in long-term survivors after HSCT through retrospective studies; to provide guidelines for screening and prevention of late complications and recommendations on screening and prevention of late effects after HSCT; and to coordinate education in the field of long-term survivorship.
ChairpersonRafael Duarte
Catalan Institute of OncologyHospital Duran i ReynalsAv. Gran Vía 199-203L`Hospitalet de Llobregat08908 Barcelona SPAINTel: +34 93 260 7750Fax: +34 93 260 7353rduarte@iconcologia.net
SecretaryGrzegorz W. Basak Department of Hematology, Oncology and Internal Diseases
The Medical University of Warsaw
1A Banacha Str.
02-097 Warsaw
POLAND
Tel: +48(22) 599 26 40
Fax: +48(22) 599 14 18
gbasak@ib.amwaw.edu.pl
Lymphoma
The LWP takes care of scientific and educational activities related to transplantations for lymphoma, which represents the largest single entity in the EBMT with almost 100,000 registered transplantations to date. The LWP runs seven scientific subcommittees: Hodgkin’s lymphoma, Indolent lymphoma, T cell lymphoma, Aggressive B cell lymphoma, Mantle cell lymphoma, Outreach, and Education.
ChairpersonPeter DregerUniversity of Heidelberg
Medizinische Klinik u. Poliklinik V
Im Neuenheimer Feld 410
69120 Heidelberg
GERMANY
SecretaryStephen Paul RobinsonConsultant Haematologist
Bone Marrow Transplant Unit
University Hospital Bristol NHS Foundation Trust
Upper Maudlin Street
Bristol BS2 8BJ
United Kingdom
Tel: +44 (0)117 342 8523
Fax: +44 (0)117 342 8628
Stephen.Robinson@UHBristol.nhs.uk
Paediatric Diseases
The PDWP aims to support research and education to improve the availability, safety, and efficacy of HSCT and other cellular therapeutics for children and adolescents; to engage and promote active co-operation with all EBMT working parties treating children and adolescents in an effort to meet the total needs of the full spectrum of paediatric HSCT patients; to initiate and perform prospective, collaborative, GCP-conform studies for malignant and non malignant paediatric diseases; to develop further the close collaboration with experts from the Leukaemia/Chemotherapy national frontline studies in order to define the optimal timing of HSCT and incorporate transplant recommendations into the disease specific protocols; to implement the new regulations on paediatric medicines from the EMEA; to offer physicians and nursing staff from small or new centres practical training and fellowships in experienced transplantation units through a European Collaborative Paediatric HSCT network; to further develop established Paediatric Standards within the Accreditation Process through JACIE to guarantee and maintain a high quality of patient care and experience.
ChairpersonChristina Peters St. Anna Kinderspital
BMT Unit
Kinderspitalgasse 6
1090 Vienna
AUSTRIA
Tel: +43 1 40 170 1250
Fax: +43 1 40 170 7000
christina.peters@stanna.at
SecretaryAdriana BalduzziCentro Trapianti di Midollo Osseo
Clinica Pediatrica Università di Milano Bicocca
A.O. San Gerardo.
Via Pergolesi 33
20900 Monza
ITALY
Tel: +39 039 233 2442 / 3523 / 3513
Fax: +39 039 233 3523
a.balduzzi@hsgerardo.org
Solid Tumours
The STWP is dedicated to pre-clinical, translational and clinical studies of cell therapy for solid tumours, including autologous and allogeneic stem cell transplant, active and adoptive immunotherapy, lymphoablative therapy with expanded T cells.
ChairpersonMarco Bregni Department of Oncology
Scientific Institute San Raffaele
Via Olgettina 60
Milan
ITALY
Tel: +39 02 26432357
Fax: +39 02 26437126
marco.bregni@hsr.it
SecretaryJacques-Olivier BayService de Thérapie Cellulaire et d'Hématologie Clinique Adultes
Hotel Dieu
11 Boulevard Léon Malfreyt
63000 Clermont-Ferrand
FRANCE
Tel: +33 473 750 076
Fax: +33 473 750 067
jobay@chu-clermontferrand.fr